EVAX Gross Margin

The Gross Margin of Evaxion A/S (EVAX) is 7775.20%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

EVAX Gross Margin - Historical Value

Date	Value
2024-12-31	7775.20%

EVAX Gross Margin - Peers Comparison

Ticker	Name	Value
AYLA	Old Ayala Inc	-
FLUO.ST	Fluoguide AS	7775.20%
GLTO	Galecto Inc	7775.20%
LPTX	Leap Therapeutics Inc	7775.20%
ONC.TO	Oncolytics Biotech Inc	7775.20%
PDSB	PDS Biotechnology Corp	7775.20%
ALLR.ST	Allarity Therapeutics A/S	-175.91%
APRE	Aprea Therapeutics Inc	7775.20%
WLLW.TO	Willow Biosciences Inc	-809.99%
LGVN	Longeveron Inc	78.76%
PSTI	Pluristem Therapeutics Inc	100.00%
SYBX	Synlogic Inc	7775.20%
ARAV	Aravive Inc	7775.20%
CRVS	Corvus Pharmaceuticals Inc	7775.20%
GMAB.CO	Genmab A/S	95.42%
LUMO	Lumos Pharma Inc	7775.20%
BIOPOR.CO	Bioporto A/S	67.68%
DYAI	Dyadic International Inc	65.82%
CYCN	Cyclerion Therapeutics Inc	7775.20%
TCON	TRACON Pharmaceuticals Inc	7775.20%
INMB	INmune Bio Inc	7775.20%
SLNO	Soleno Therapeutics Inc	40.98%
SLS	Sellas Life Sciences Group Inc	90.00%
CLGN	Collplant Biotechnologies Ltd	-160.00%
BCLI	Brainstorm Cell Therapeutics Inc	7775.20%
MRZM	Marizyme Inc	70.87%
ORPHA.CO	Orphazyme A/S	7775.20%
PTN	Palatin Technologies Inc	97.83%
SANION.ST	Saniona AB	85.03%
AIKI	Aikido Pharma Inc	100.00%
ATNM	Actinium Pharmaceuticals Inc	100.00%
ATNF	180 Life Sciences Corp	7775.20%
SCPS	Scopus Biopharma Inc	7775.20%
ZEAL.CO	Zealand Pharma A/S	87.44%
ALRN	Aileron Therapeutics Inc	7775.20%
ASND	Ascendis Pharma A/S	87.83%
ANIX	Anixa Biosciences Inc	97.00%
BAVA.CO	Bavarian Nordic A/S	49.31%